Bone protective effect of sinomenine against monosodium iodoacetate induced knee and hip injury in rat model: an inflammatory pathway
- PMID: 38324802
- PMCID: PMC10852535
- DOI: 10.1590/acb390924
Bone protective effect of sinomenine against monosodium iodoacetate induced knee and hip injury in rat model: an inflammatory pathway
Abstract
Purpose: Osteoarthritis (OA) is a degenerative joint disease which is categorized via destruction of joint cartilage and it also affects the various joints, especially knees and hips. Sinomenine active phytoconstituents isolated from the stem of Sinomenium acutum and already proof anti-inflammatory effect against the arthritis model of rodent. In this experimental protocol, we scrutinized the anti-osteoarthritis effect of sinomenine against monosodium iodoacetate (MIA) induced OA in rats.
Methods: MIA (3 mg/50 μL) was used for inducing the OA in the rats, and rats received the oral administration of sinomenine (2.5, 5 and 7.5 mg/kg body weight) up to the end of the experimental study (four weeks). The body and organs weight were estimated. Aggrecan, C-terminal cross-linked telopeptide of type II collagen (CTX-II), glycosaminoglycans (GCGs), monocyte chemoattractant protein-1 (MCP-1), Interferon gamma (IFN-γ), antioxidant, inflammatory cytokines, inflammatory mediators and matrix metalloproteinases (MMP) were analyzed.
Results: Sinomenine significantly (P < 0.001) boosted the body weight and reduced the heart weight, but the weight of spleen and kidney remain unchanged. Sinomenine significantly (P < 0.001) reduced the level of nitric oxide, MCP-1 and improved the level of aggrecan, IFN-γ and GCGs. Sinomenine remarkably upregulated the level of glutathione, superoxide dismutase and suppressed the level of malonaldehyde. It effectually modulated the level of inflammatory cytokines and inflammatory mediators and significantly (P < 0.001) reduced the level of MMPs, like MMP-1, 2, 3, 9 and 13.
Conclusions: Sinomenine is a beneficial active agent for the treatment of OA disease.
Conflict of interest statement
Figures








Similar articles
-
Evaluating the Anti-Osteoarthritis Potential of Standardized Boswellia serrata Gum Resin Extract in Alleviating Knee Joint Pathology and Inflammation in Osteoarthritis-Induced Models.Int J Mol Sci. 2024 Mar 12;25(6):3218. doi: 10.3390/ijms25063218. Int J Mol Sci. 2024. PMID: 38542192 Free PMC article.
-
Cartilage protective and anti-analgesic effects of ALM16 on monosodium iodoacetate induced osteoarthritis in rats.BMC Complement Altern Med. 2019 Nov 21;19(1):325. doi: 10.1186/s12906-019-2746-7. BMC Complement Altern Med. 2019. PMID: 31752825 Free PMC article.
-
Time-Dependent Effect of Eggshell Membrane on Monosodium-Iodoacetate-Induced Osteoarthritis: Early-Stage Inflammation Control and Late-Stage Cartilage Protection.Nutrients. 2024 Jun 14;16(12):1885. doi: 10.3390/nu16121885. Nutrients. 2024. PMID: 38931240 Free PMC article.
-
Anti-osteoarthritis, Bone Protective and Antiinflammatory Effect of Lusianthridin against Monosodium Iodoacetate Induced Osteoarthritis via Suppression of Inflammatory Pathway.J Oleo Sci. 2024;73(1):85-98. doi: 10.5650/jos.ess23127. J Oleo Sci. 2024. PMID: 38171734
-
Isorhamnetin ameliorates inflammatory responses and articular cartilage damage in the rats of monosodium iodoacetate-induced osteoarthritis.Immunopharmacol Immunotoxicol. 2019 Aug;41(4):504-512. doi: 10.1080/08923973.2019.1641723. Epub 2019 Jul 25. Immunopharmacol Immunotoxicol. 2019. PMID: 31342791
References
-
- Pang KL, Ghafar NA, Soelaiman IN, Chin KY. Protective effects of annatto tocotrienol and palm tocotrienol-rich fraction on chondrocytes exposed to monosodium iodoacetate. Appl Sci. 2021;11(20):9643–9643. doi: 10.3390/app11209643. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous